by John Conrad | May 21, 2024 | Member News
Naperville-based OWP Pharmaceuticals, a company focused on developing new treatments for neurological conditions,announced a significant step forward today. The U.S. Food and Drug Administration (FDA) has accepted their New Drug Application (NDA) for SUBVENITE®...
by John Conrad | May 21, 2024 | Member News
The future of medicine is getting a robotic arm! Astellas Pharma and Yaskawa Electric Corporation just announced a collaboration to develop a groundbreaking cell therapy ecosystem. This exciting partnership aims to bridge the gap between cutting-edge research and...
by John Conrad | May 20, 2024 | Member News
Trammell Crow Company (TCC) Chicago continues to double down on Fulton Market, one of Chicago’s hottest neighborhoods. The team recently unveiled plans for the Fulton Park Campus, a vibrant mixed-use development poised to become a hub for innovation and...
by John Conrad | May 16, 2024 | Member News
Rosalind Franklin University (RFU) recently celebrated the fifth anniversary of its Helix 51 biomedical incubator, the only one of its kind in Lake County, Illinois. The milestone coincides with the addition of four exciting new startup companies to the...
by John Conrad | May 16, 2024 | Member News
Cardio Diagnostics announced the availability of their clinical blood tests, Epi+Gen CHD and PrecisionCHD, at Family Medicine Specialists’ (FMS) newest location within the Walmart Supercenter in Round Lake Beach, Illinois. This collaboration expands access to Cardio...
by John Conrad | May 14, 2024 | Member News
AbbVie has entered into a licensing deal with Gilgamesh Pharmaceuticals to develop new treatments for psychiatric disorders. AbbVie will pay Gilgamesh an upfront payment of $65 million and up to $1.95 billion in potential milestones. Gilgamesh is developing drugs...
